JUKES: Jurnal Kesehatan Wira Buana welcomes scholarly submissions across the following manuscript types:
Journal of Kesehatan Wira Buana considers manuscripts that have not been published previously and are not under consideration by any other journal. All submissions must be written in English and undergo double-blind peer review by at least two independent reviewers with relevant expertise. The journal accepts the following types of manuscripts.
1. Original Research Article
Original research articles are the core contribution of the journal and constitute the majority of articles published in each issue. They report primary research in Midwifery. Accepted designs include randomized and non-randomized trials, cohort studies, case-control studies, cross-sectional studies, qualitative research, and mixed-methods studies.
Manuscripts should follow the IMRaD structure (Introduction, Methods, Results, and Discussion) and should not exceed 3,000-5,000 words, excluding the abstract, tables, figures, and references. A structured abstract of no more than 250 words and 3-5 keywords are required. Reporting must follow the relevant international guidelines: CONSORT for randomized controlled trials, STROBE for observational studies, COREQ or SRQR for qualitative research, STARD for diagnostic accuracy studies, and TREND for non-randomized intervention studies. Clinical trials must be registered in a WHO-recognized trial registry before participant enrollment begins.
2. Systematic Review and Meta-Analysis
Systematic reviews and meta-analyses synthesize existing evidence using a transparent and reproducible methodology. Authors must describe the search strategy across at least two reputable databases (e.g., Scopus, PubMed/MEDLINE, Web of Science, or CINAHL), the eligibility criteria, the study selection process, and the assessment of risk of bias using an appropriate tool (e.g., Cochrane RoB, JBI Critical Appraisal Tools, or the Newcastle-Ottawa Scale). Reporting must follow the PRISMA 2020 statement, including a flow diagram, and the review protocol should be registered in PROSPERO or OSF. Manuscripts should be 4,000-6,000 words.
3. Scoping Review and Narrative Review
Scoping reviews map the extent, nature, and gaps of research on a given topic, following the PRISMA-ScR checklist and the framework of Arksey and O'Malley or the JBI methodology. Narrative reviews are accepted by invitation of the editors or when authored by recognized experts with a strong publication record on the topic. They must provide a critical synthesis rather than a purely descriptive summary. Manuscripts should not exceed 5,000 words.
4. Case Report and Case Series
Case reports and case series are accepted selectively and only when they describe rare conditions, atypical presentations, previously unreported adverse events, or innovative management with clear clinical learning value. Authors must provide written informed consent from the patient and follow the CARE guidelines. Patient identity must be fully protected. Manuscripts should be 1,500-2,500 words with no more than 20 references. To maintain the journal's scientific focus, the number of case reports published in each issue is limited.
5. Short Communication
Short communications present concise but significant original findings, such as preliminary results or studies of limited scope that warrant rapid dissemination. They should not exceed 2,000 words, with an abstract of up to 150 words, no more than two tables or figures, and up to 20 references.
6. Study Protocol and Methodological Article
Study protocols describe the design of a research project that has received ethical approval and has been registered but is not yet completed, and should follow the SPIRIT guidelines. Methodological articles report the development, cross-cultural adaptation, or validation of instruments and methods, and must provide adequate evidence of validity and reliability (e.g., following the COSMIN guidelines).
7. Letter to the Editor and Commentary
Letters to the editor provide critical responses to articles published in this journal within the previous 12 months, or brief commentary on current health issues. They should not exceed 1,000 words and should include no more than 10 references. The authors of the article under discussion will be given the opportunity to reply. The journal publishes only a limited number of such items.
General Requirements for All Manuscript Types
All manuscripts must comply with the following requirements, in line with the standards of reputable international scholarly publishing.
Research and publication ethics. Studies involving human participants or animals must obtain ethical approval from an accredited ethics committee. The approval number and date must be stated in the Methods section, and the study must adhere to the Declaration of Helsinki. The journal follows the guidelines of the Committee on Publication Ethics (COPE) and the recommendations of the International Committee of Medical Journal Editors (ICMJE), covering the prevention of plagiarism, duplicate publication, and data fabrication or falsification, as well as the handling of complaints, corrections, and retractions. All submissions are screened using similarity-detection software, and the similarity index must not exceed 20%.
Authorship and transparency. The contribution of each author must be declared using the CRediT taxonomy, and authors are encouraged to provide an ORCID iD. Authors must disclose conflicts of interest and funding sources and include a data availability statement. Any use of generative artificial intelligence tools must be disclosed; such tools cannot be listed as authors.
Abstract and references. The title, abstract, and keywords must be written in clear English and accurately reflect the content of the manuscript. References should follow a consistent style (Vancouver or APA 7th edition) and be managed with reference software. Original research articles should cite approximately 25-40 references, the majority (ideally at least 80%) drawn from reputable journals published within the last 10 years. Authors are encouraged to cite international literature and to include DOIs.
Novelty and contribution. Manuscripts must demonstrate novelty, significance for health practice or policy, and relevance to an international readership. Submissions of purely local interest without broader implications, or those with weak methodology, may be rejected at the initial editorial screening (desk rejection).
